biotech
$200M Venture Capital For Emerging Public Health Risks
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on February 16, 2006
BlogPicture

Kleiner Perkins Caufield & Byers is a reputable venture capital firm in Silicon Valley which has provided financial backing to some of the best known technology and biotech firms today, including Google Inc., Genentech, Inc, Sun Microsystems, Inc, and Amazon.com Inc..

This time, Kleiner aims its venture capital at emerging public health risks. The firm said yesterday that it had raised a total of $200 million for the KPCB Pandemic and Bio Defense Fund, which will be invested in companies working on fighting emerging biological threats, including the bird flu pandemic.

Kleiner also raised $600 million for its 12th general venture fund, $100 million of which will be invested in clean energy technologies.

Read more from Washington Post.

Permalink: $200M Venture Capital For Emerging Public Health Risks
Tags: venture  healthcare  biotech  capital  health  venture+capital  public+health  emerging+public 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/15640
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for $200M Venture Capital For Emerging Public Health Risks:

  • Currently 8.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.00 out of 1 vote(s) cast.
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!